Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Vinorelbine bulk supplier for pharma manufacturers

Vinorelbine Suppliers & Bulk Manufacturers

Available Forms: Intravenous Injection, Oral Capsule

Available Strengths: Injection: 10 mg/mL; Capsule : 20 mg, 30 mg, 40 mg

Reference Brands: Navelbine® , Alocrest (US & EU)

Category: Oncology Cancer Care

Vinorelbine (brand Navelbine®) is a chemotherapy drug used for non-small cell lung cancer and advanced breast cancer. Available as IV injection (10 mg/mL) and oral capsules (20 mg, 30 mg, 40 mg), it disrupts microtubule formation to stop cancer cell division. Sourced by GMP-compliant B2B suppliers, it is widely available in the US and EU for reliable oncology treatment.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Vinorelbine, marketed as Navelbine®, is an essential chemotherapy agent used for the treatment of non-small cell lung cancer (NSCLC) and advanced breast cancer. Available as an intravenous injection and oral capsules, with strengths like 10 mg/mL (IV) and 20 mg, 30 mg, and 40 mg (oral), Vinorelbine inhibits cell division by disrupting microtubule formation. Widely sourced by B2B pharmaceutical suppliers, Vinorelbine is available globally, including in the US and EU. Manufactured under GMP standards, it provides reliable therapy options for hospitals and oncology centers fighting aggressive cancers.

Vinorelbine — third party manufacturing & bulk supply

Vinorelbine is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Vinorelbine is supplied as Intravenous Injection, Oral Capsule — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Vinorelbine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Vinorelbine →
Back to Listing

Frequently Asked Questions

Vinorelbine tartrate is an anticancer (chemotherapy) medicine used for the treatment of non-small cell lung cancer (NSCLC) and metastatic breast cancer. It works by stopping cancer cells from dividing and spreading in the body.

Vinorelbine is a semi-synthetic vinca alkaloid, chemically derived from catharanthine and vindoline, which are natural compounds extracted from the Madagascar periwinkle plant (Catharanthus roseus).It is formulated as Vinorelbine tartrate, used for injection or soft gelatin capsules.

Common trade names include:Navelbine® (by Pierre Fabre), Velbe, Alocrest® (regional), Multiple generic brands available globally as Vinorelbine Tartrate Injection or Vinorelbine Capsules.

Pierre Fabre Medicament – Original manufacturer of Navelbine® (France)Generic manufacturers include Teva, Dr. Reddy’s, Sun Pharma, Cipla, and Intas for worldwide supply.

The generic name is Vinorelbine tartrate.

The primary brand name is Navelbine

Navelbine® is manufactured by Pierre Fabre Laboratories in France, Generic Vinorelbine formulations are manufactured by Indian, European, and US companies under strict GMP and oncology-grade sterile conditions.

Related Products

Vinblastine Sulfate

Strength:
10 mg/10 mL (1 mg/mL), 10 mg/1 mL

Form: Injection

Reference Brands: Velban® (EU & US)

View Details
Octreotide Acetate Pen

Strength:
25000 mcg, 7000 mcg

Form: injection (prefilled syringe)

Reference Brands: Bynfezia Pen (USA)

View Details
Topotecan Capsule

Strength:
Capsule: 1 mg, 2.5 mgL

Form: Oral capsules

Reference Brands: Hycamtin® (EU & US)

View Details
Doxorubicin Liposomal

Strength:
20 mg/10 mL (2 mg/mL), 50 mg/25 mL (2 mg/mL)

Form: Liposomal Injection (

Reference Brands: Doxil® , Caelyx® (EU & US)

View Details
Midostaurin

Strength:
25 mg

Form: Capsules

Reference Brands: Rydapt (USA/EU)

View Details
Mitoxantrone

Strength:
2 mg/mL

Form: Injection

Reference Brands: Novantrone (USA)

View Details
Dordaviprone Hydrochloride

Strength:
125 mg

Form: Capsules

Reference Brands: Modeyso (USA)

View Details
Tafasitamab‑Cxix

Strength:
200 mg

Form: Injection

Reference Brands: Monjuvi (USA), Minjuvi (EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.